Quantel Medical (Quantel), a global ophthalmic medical device company dedicated to developing leading technologies to improve the diagnosis and treatment of ocular diseases, announced it has been awarded a €3 million competitive tender for ophthalmic laser equipment.
Under the terms of a supply agreement signed by the Directorate General of Armed Forces Medical Services of the Indian Ministry of Defense, Quantel Medical will provide 61 photocoagulator lasers (532nm Supra with Suprascan) for use in 53 military hospitals across India. The 532nm Supra with Suprascan is a diverse and versatile laser platform capable of delivering a number of Multispot and MicroPulse patterns.
This agreement will put an extremely powerful treatment option in the hands of physicians who treat patients with diabetic eye disease, and it is a platform that can be adapted to use for other applications as well. Laser treatment of diabetes is in many cases as effective as medical treatment, and it is demonstrated to be much more cost effective.
Jean-Marc Gendre, CEO of Quantel Medical